SCHEMBL5111673

SCHEMBL5111673

CC(Oc1ccc(OCc2ccccc2)cc1)C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.74
L3MBTL1 Q9Y468 1/20 0.74
PPARG P37231 5/20 0.66
PPARA Q07869 5/20 0.66
CYP1A2 P05177 2/20 0.63
CYP2C19 P33261 2/20 0.63
GAA P10253 1/20 0.63
CYP2C9 P11712 1/20 0.63
PKM P14618 1/20 0.63
MAOB P27338 1/20 0.59
NR4A1 P22736 1/20 0.58
NR4A2 P43354 1/20 0.58
NR4A3 Q92570 1/20 0.58
PTGS1 P23219 1/20 0.56
SLC6A2 P23975 1/20 0.56
PTGS2 P35354 1/20 0.56
SLC6A3 Q01959 1/20 0.56
HIF1A Q16665 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
LTA4H P09960 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9471057 1.00 LMNA (0.74) LMNAL3MBTL1PPARGPPARACYP1A2
SCHEMBL11730903 0.95 L3MBTL1 (0.68) LMNAL3MBTL1PPARGPPARACYP1A2
SCHEMBL10732880 0.89 LMNA (0.72) LMNAL3MBTL1PPARGPPARACYP1A2
SCHEMBL10867537 0.88 LMNA (0.70) LMNAL3MBTL1PPARGPPARACYP1A2
SCHEMBL28724154 0.88 LMNA (0.70) LMNAL3MBTL1PPARGPPARACYP1A2
SCHEMBL28165618 0.88 MAOB (0.60) LMNAL3MBTL1PPARGPPARAPKM
SCHEMBL1744700 0.87 CYP1A2 (0.64) LMNAL3MBTL1PPARGPPARACYP1A2
SCHEMBL27516720 0.86 CYP1A2 (0.62) LMNAL3MBTL1PPARGPPARACYP1A2
SCHEMBL1746424 0.86 FFAR1 (0.62) LMNAL3MBTL1PPARGPPARACYP1A2
SCHEMBL11008605 0.86 NR4A2 (0.61) LMNAL3MBTL1PPARGPPARAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4547582-A Method of producing herbicide intermediates STAUFFER CHEMICAL COMPANY (US) 1985-10-15 US claimed
EP-2310371-B1 PPAR AGONIST COMPOUNDS AND PREPARATION AND USES THEREOF FOR TREATING DIABETES AND/OR DYSLIPIDEMIA GENFIT (FR) 2013-05-15 EP disclosed
US-20080146631-A1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS BROOKS DAWN ALISA 2008-06-19 US disclosed
US-7351728-B2 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists ELI LILLY AND COMPANY (US) 2008-04-01 US disclosed
EP-1313715-B1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS LILLY CO ELI (US) 2007-08-01 EP disclosed
US-6982278-B2 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists ELI LILLY AND COMPANY (US) 2006-01-03 US disclosed
US-20050250825-A1 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists BROOKS DAWN A 2005-11-10 US disclosed
US-20040024034-A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists BROOKS DAWN ALISA (US) 2004-02-05 US disclosed
EP-1313715-A1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS ELI LILLY AND COMPANY (US) 2003-05-28 EP disclosed
WO-2002018355-A1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS ELI LILLY AND COMPANY (US) 2002-03-07 WO disclosed
WO-1994013647-A1 (2-QUINOXALINYLOXY)PHENOXYPROPANOIC ACIDS AND RELATED DERIVATIVES AS ANTICANCER AGENTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-06-23 WO disclosed
WO-1994000532-A1 1-METHYL-2-OXAALKOXY-DERIVATIVES MERCK PATENT GMBH (DE) 1994-01-06 WO disclosed
EP-0121871-B1 PROPIONIC-ACID ESTERS AND THEIR USE IN COMBATING WEEDS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1988-01-20 EP disclosed
EP-0178054-A2 Herbicide intermediates and production thereof STAUFFER CHEMICAL COMPANY (US) 1986-04-16 EP disclosed
US-4547582-A Method of producing herbicide intermediates STAUFFER CHEMICAL COMPANY (US) 1985-10-15 US disclosed
US-4547582-A Method of producing herbicide intermediates STAUFFER CHEMICAL COMPANY (US) 1985-10-15 US disclosed
US-4540804-A Herbicide intermediates STAUFFER CHEMICAL COMPANY (US) 1985-09-10 US disclosed
US-4537984-A Process for producing 2-(4-hydroxyphenoxy) propionate derivatives NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1985-08-27 US disclosed
EP-0129034-A1 process for producing 2-(4-hydroxyphenoxy) propionate derivatives NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1984-12-27 EP disclosed
EP-0121871-A1 Propionic-acid esters and their use in combating weeds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250825-A1 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists PPARA, PPARG, PPARD LMNA 3367/4885L3MBTL1 3955/4885PPARG 2/4885
US-20040024034-A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists PPARA, PPARG, PPARD LMNA 3537/4885L3MBTL1 3347/4885PPARG 2/4885
US-20080146631-A1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS PPARA, PPARG, PPARD LMNA 1860/4885L3MBTL1 3714/4885PPARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.